"Amyloid Precursor Protein Secretases/antagonists and inhibitors"[MeSH] - Search Results

Year	Number of Results
2006	47
2007	136
2008	146
2009	177
2010	219
2011	200
2012	231
2013	202
2014	180
2015	164
2016	144
2017	136
2018	126
2019	133
2020	99
2021	73
2022	13
2023	2
2024	2

1

Therapeutic Targeting of Amyloid Precursor Protein and its Processing Enzymes for Breast Cancer Treatment.

Danish Rizvi SM, Hussain T, Subaiea GM, Shakil S, Ahmad A. Danish Rizvi SM, et al. Curr Protein Pept Sci. 2018;19(9):841-849. doi: 10.2174/1389203718666170828123924. Curr Protein Pept Sci. 2018. PMID: 28847292 Review.

2

Classification of beta-site amyloid precursor protein cleaving enzyme 1 inhibitors by using machine learning methods.

Singh R, Ganeshpurkar A, Ghosh P, Pokle AV, Kumar D, Singh RB, Singh SK, Kumar A. Singh R, et al. Chem Biol Drug Des. 2021 Dec;98(6):1079-1097. doi: 10.1111/cbdd.13965. Epub 2021 Oct 11. Chem Biol Drug Des. 2021. PMID: 34592057

3

γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.

Pont MJ, Hill T, Cole GO, Abbott JJ, Kelliher J, Salter AI, Hudecek M, Comstock ML, Rajan A, Patel BKR, Voutsinas JM, Wu Q, Liu L, Cowan AJ, Wood BL, Green DJ, Riddell SR. Pont MJ, et al. Blood. 2019 Nov 7;134(19):1585-1597. doi: 10.1182/blood.2019000050. Blood. 2019. PMID: 31558469 Free PMC article.

4

Selective Secretase Targeting for Alzheimer's Disease Therapy.

Miranda A, Montiel E, Ulrich H, Paz C. Miranda A, et al. J Alzheimers Dis. 2021;81(1):1-17. doi: 10.3233/JAD-201027. J Alzheimers Dis. 2021. PMID: 33749645 Review.

5

Insight γ-Secretase: Structure, Function, and Role in Alzheimer's Disease.

Mal S, Malik U, Pal D, Mishra A. Mal S, et al. Curr Drug Targets. 2021;22(12):1376-1403. doi: 10.2174/1389450121999201230203709. Curr Drug Targets. 2021. PMID: 33390127 Review.

6

Proteolytic processing of Neuregulin-1.

Willem M. Willem M. Brain Res Bull. 2016 Sep;126(Pt 2):178-182. doi: 10.1016/j.brainresbull.2016.07.003. Epub 2016 Jul 5. Brain Res Bull. 2016. PMID: 27393467 Review.

7

BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease.

Moussa-Pacha NM, Abdin SM, Omar HA, Alniss H, Al-Tel TH. Moussa-Pacha NM, et al. Med Res Rev. 2020 Jan;40(1):339-384. doi: 10.1002/med.21622. Epub 2019 Jul 26. Med Res Rev. 2020. PMID: 31347728 Review.

8

γ-Secretase inhibitors and modulators: Mechanistic insights into the function and regulation of γ-Secretase.

Nie P, Vartak A, Li YM. Nie P, et al. Semin Cell Dev Biol. 2020 Sep;105:43-53. doi: 10.1016/j.semcdb.2020.03.002. Epub 2020 Apr 2. Semin Cell Dev Biol. 2020. PMID: 32249070 Free PMC article. Review.

9

Probing Mechanisms and Therapeutic Potential of γ-Secretase in Alzheimer's Disease.

Wolfe MS. Wolfe MS. Molecules. 2021 Jan 13;26(2):388. doi: 10.3390/molecules26020388. Molecules. 2021. PMID: 33450968 Free PMC article. Review.

10

Advancing Alzheimer's Disease Treatment: Lessons from CTAD 2018.

Vellas B, Bain LJ, Touchon J, Aisen PS. Vellas B, et al. J Prev Alzheimers Dis. 2019;6(3):198-203. doi: 10.14283/jpad.2019.11. J Prev Alzheimers Dis. 2019. PMID: 31062835 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

2,103 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

2,103 results

Results by year